Morton Grove
- All
- News
-
US Man Found Guilty Of Murdering 19-Year-Old Indian-Origin Student
Gaege Bethune has been convicted of the first-degree murder of an Indian-origin student after four years of untiring efforts by his family to seek justice, according to a media report.
-
Wockhardt Plunges After US Drug Regulator Warns Subsidiary
After a weak opening, shares of the company further went down by 6.67 per cent to Rs 701 on BSE.
-
USFDA Issues Warning Letter To Wockhardt's US Arm
The company, however, did not provide any details about the reasons for the issuance of warning letter and when it was issued.
-
Wockhardt Q1 Net Profit Plunges 94% on Plant Bans
Generic drugmaker Wockhardt Ltd on Tuesday said its quarterly net profit plunged 94 per cent, as U.S. Food and Drug Administration bans on its manufacturing plants continued to take a toll.
-
FDA Criticises Quality Control, Training at Wockhardt US Plant
Wockhardt's managing director Murtaza Khorakiwala said last week that FDA had expressed concerns over production processes at the US unit. He said the company had responded to the observations but declined to give details.
-
USFDA Finds Procedural Lapses at Wockhardt's US Facility
Wockhardt's Managing Director Murtaza Khorakiwala recently told analysts that FDA had in March inspected the company's Chicago-based Morton Grove Pharmaceuticals unit, which accounts for more than 50 per cent of its sales in the United States.
-
Missing Indian-origin student in US found dead
A 19-year-old Indian-origin student of the Southern Illinois University, who had gone missing last week, has been found dead.
-
US Man Found Guilty Of Murdering 19-Year-Old Indian-Origin Student
Gaege Bethune has been convicted of the first-degree murder of an Indian-origin student after four years of untiring efforts by his family to seek justice, according to a media report.
-
Wockhardt Plunges After US Drug Regulator Warns Subsidiary
After a weak opening, shares of the company further went down by 6.67 per cent to Rs 701 on BSE.
-
USFDA Issues Warning Letter To Wockhardt's US Arm
The company, however, did not provide any details about the reasons for the issuance of warning letter and when it was issued.
-
Wockhardt Q1 Net Profit Plunges 94% on Plant Bans
Generic drugmaker Wockhardt Ltd on Tuesday said its quarterly net profit plunged 94 per cent, as U.S. Food and Drug Administration bans on its manufacturing plants continued to take a toll.
-
FDA Criticises Quality Control, Training at Wockhardt US Plant
Wockhardt's managing director Murtaza Khorakiwala said last week that FDA had expressed concerns over production processes at the US unit. He said the company had responded to the observations but declined to give details.
-
USFDA Finds Procedural Lapses at Wockhardt's US Facility
Wockhardt's Managing Director Murtaza Khorakiwala recently told analysts that FDA had in March inspected the company's Chicago-based Morton Grove Pharmaceuticals unit, which accounts for more than 50 per cent of its sales in the United States.
-
Missing Indian-origin student in US found dead
A 19-year-old Indian-origin student of the Southern Illinois University, who had gone missing last week, has been found dead.
